This concept is supported by several studies showing that angiogenic factors, such as VEGF-A stimulate biliary proliferation, liver fibrosis and lipogenesis associated with increased hepatic steatosis in cholestatic models [59, 61, 62]. The gene discussed is VEGFA; the disease is fatty liver disease.